>10M women struggle with infertility in the U.S. 1
Extend care beyond diagnosis with in-office treatment options that help close the fertility care gap.
1. Centers for Disease Control and Prevention. Key Statistics from the National Survey of Family Growth. https://www.cdc.gov/nchs/nsfg/key_statistics/i-keystat.htm
2. Centers for Disease Control and Prevention. 2022 Assisted Reproductive Technology (ART) Fertility Clinic and National Summary Report. US Dept of Health and Human Services; 2024.
"FemaSeed is a progressive solution for the front end of care that will be a valuable addition to our suite of options, demonstrating our commitment to offer patients choices as they embark or continue their journey to parenthood."
Dr. Kolb · President, HRC Fertility, California
The reality
3. NSFG – Listing I – Key Statistics from the National Survey of Family Growth. Centers for Disease Control and Prevention, 16 Dec. 2022. https://www.cdc.gov/nchs/nsfg/key_statistics/i-keystat.htm#infertility
4. Kumar N, et al. (2015). Trends of male factor infertility, an important cause of infertility: A review of literature. J Hum Reprod Sci. doi: 10.4103/0974-1208.170370
Step 1 — Evaluate
Diagnosis is the critical first step in guiding both female patients and male partners toward treatment.
5. Agarwal A, et al. Home sperm testing device versus laboratory sperm quality analyzer: comparison of motile sperm concentration. Fertility and Sterility, December 2018.
Step 2 — Treat
Simple in-office insemination to the fallopian tube enhances natural fertilization.
6. Liu JH, et al. (2024). FemaSeed Directional Intratubal Artificial Insemination for Couples with Male-Factor or Unexplained Infertility Associated with Low Male Sperm Count. J Gynecol Reprod Med, 8(2), 01–12. doi: 10.33140/JGRM.08.02.08
Clinical Evidence
1 in 4 women became pregnant with FemaSeed 6
A substantially higher rate than historic IUI for low sperm count, giving your patients a faster, more effective path to pregnancy in the OB/GYN office.
6. Liu JH, et al. (2024). FemaSeed Directional Intratubal Artificial Insemination for Couples with Male-Factor or Unexplained Infertility Associated with Low Male Sperm Count. J Gynecol Reprod Med, 8(2), 01–12. doi: 10.33140/JGRM.08.02.08.
Time to pregnancy
Fertility declines with age, and delays reduce chances of success, even with IVF. FemaSeed shortens the path to 1–3 cycles, performed entirely in your office.
FemaSeed is performed in your office, reducing time-to-treatment and eliminating specialist referral delays.
"We had experienced so much loss and so many failures that we were in a bit of a defeated mode, but we were so incredibly thankful to know it [FemaSeed] worked. Now I'm seven months pregnant with our first child and could not be happier."
Aslyn, 39
Two losses (ectopic & miscarriage), medication, failed IUI
Practice value
Fill out the form below and a Femasys representative will contact you.